Perception of hepatitis C infection and its management in women infected by HIV following intravenous us of drugs;Perception de la co-infection par le VHC et de sa prise en charge chez les femmes infectées par le VIH après usage intraveineux de drogues

Presse Medicale

Volumn 32, Issue 35, 2003, Pages 1642-1648

  Coulon, Myriam ^a,b   Rey, Dominique ^a,b   Loubiere, Sandrine ^a,b   Fuzibet, Jean Gabriel ^c   Gastaut, Jean Albert ^d,e   Obadia, Yolande ^a,b  

^a OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^b Recherche Médicale Montpellier   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; CLINICAL ARTICLE; DRUG ABUSE; FEMALE; FOLLOW UP; FRANCE; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIFESPAN; LIVER BIOPSY; LIVER FUNCTION; PATIENT CARE; PATIENT COUNSELING; PREGNANCY; REVIEW; SCREENING; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERVIEWS; PARIS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0142183226     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzalez J, Pedreira J, Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999; 31 Suppl 1: 119-23.
2. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86: 655-61.
3. Soriano V, Garcia-Samaniego J, Valencia E et al. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 1999; 15: 1-4.
4. Monga HK, Rodriguez-Barradas MC, Breaux K et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33: 240-7.
5. Pol S, Lamorthe B, Thi NT et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998; 28: 945-50.
6. Backmund M, Meyer K, Von Zielonka M, Eichenlaub D. Treatment of hepatitis C infection in injection drug users. Hepatology 2001; 34: 188-93.
7. Bonacini M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 2000; 160:3365-73.
8. Delfraissy JF. Prise en charge thérapeutique des personnes infectées par le VIH. Paris: Matillon Y et Durieux (Eds); 2000.
9. Thélot B, Pialoux G, Delhommeau A. Epidémiologie hospitalière des patients coinfectés par le VIH et le VHC. BEH 2000; 39: 171-3.
10. Falck-Ytter Y, Kale H, Mullen KD et al. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288-92.
11. Cadranel JF, Di Martino V, Cesbron H et al. Epidemiological characteristics of hepatitis C in a primary referral hospital. Impact of systematic screening on therapeutic management and natural history. Gastroenterol Clin Biol 2000; 24: 161-7.
12. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997; 25: 1490-6.
13. Brown JL. Efficacy of combined interferon and ribavirin for treatment of hepatitis C. Lancet 1998; 351: 78-9.
14. Reichard O, Norkrans G, Fryden A, et al. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet 1998;351:83-7.
15. Di Martino V, Thevenot T, Boyer N et al. HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C. AIDS 2002; 16: 441-5.
16. Carrieri MP, Moatti JP, Vlahov D, et al. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. Manif 2000 Study Group. J Epidemiol Community Health 1999; 53: 4-8.
17. Rotily M, Loubière S, Prudhomme J et al. Facteurs associés à la proposition du dépistage de l'hépatite C en médecine générale. Gastroenterol Clin Biol 2002; 26: 261-9.
18. Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2001; 61: 211-15.
19. Zanetti AR, Tanzi E, Newell ML. Mother-to-infant transmission of hepatitis C virus. J Hepatology 1999; 31 Suppl 1: 96-100.
20. Blanchet A. L'entretien dans les Sciences Sociales. Paris; 1985.
21. Bardin L. L'analyse de contenu. Paris: PUF; 1977.
22. Best D, Noble A, Finch E et al. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999; 319: 290-1.
23. Latt NC, Spencer JD, Beeby PJ et al. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 2000; 15: 17S-81.
24. Yeung LTF, King SM, Roberts EA. Mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 34: 223-9.
25. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36: S99-S105.
26. Buffington J, Damon S, Moyer L, Culver D. Racial differences in knowledge regarding hepatitis C virus infection. JAMA 2000; 284: 1651-2.
27. Vidal-Trecan G, Coste J, Varescon-Pousson I, Christoforov B, Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol 2000; 16: 439-45.
28. Lindsay J, Smith AM, Rosenthal DA. Uncertain knowledge: a national survey of high school students' knowledge and beliefs about hepatitis C. Aust N Z J Public Health 1999; 23: 135-9.